GlassScriptPhysician profile
Kimberly Chan
NPI 1669006045
$3,798.66
in general payments reported to CMS, 2019-2025
18 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $698 · 2023: $613 · 2024: $1,795 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,013 · Travel and Lodging: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,012.97 |
| Travel and Lodging | $953.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,214.62 | 2024 | Turbohawk |
| Stryker Corporation | $437.15 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $428.00 | 2022-2025 | Xifaxan, Trulance |
| Abbvie INC. | $406.35 | 2021-2025 | |
| Shockwave Medical, INC | $378.16 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $214.33 | 2023-2024 | Dificid |
| Madrigal Pharmaceuticals | $186.24 | 2025 | Rezdiffra |
| Kci USA, INC. | $118.14 | 2021 | |
| Vivus LLC | $88.34 | 2024-2025 | Pancreaze |
| Redhill Biopharma INC. | $52.23 | 2022-2023 | Movantik, Talicia, Aemcolo |
| Intercept Pharmaceuticals, INC. | $52.14 | 2023-2024 | Ocaliva |
| Imperative Care, INC | $48.55 | 2025 | Symphony Catheter, Prodigy Catheter |
| Phathom Pharmaceuticals, INC. | $46.83 | 2024 | Voquezna |
| Integra Lifesciences Corporation | $29.67 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Biotech, INC. | $29.30 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $23.47 | 2025 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $23.31 | 2025 | Dupixent |
| Ardelyx, INC. | $21.83 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.